CB
NVCR icon

Commerce Bank’s NovoCure NVCR Stock Holding History

Commerce Bank’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,285
Closed -$258K – 1189
2023
Q1 		$258K Buy
4,285
+22
+0.5% +$1.76K ﹤0.01% 1034
2022
Q4 		$313K Buy
4,263
+72
+2% +$5.42K ﹤0.01% 964
2022
Q3 		$318K Buy
4,191
+177
+4% +$13.8K ﹤0.01% 925
2022
Q2 		$279K Sell
4,014
-204
-5% -$15.4K ﹤0.01% 975
2022
Q1 		$349K Buy
+4,218
New +$311K ﹤0.01% 939
2021
Q3 		– Sell
-2,340
Closed -$519K – 1177
2021
Q2 		$519K Buy
2,340
+118
+5% +$23K ﹤0.01% 820
2021
Q1 		$294K Buy
2,222
+263
+13% +$41.6K ﹤0.01% 986
2020
Q4 		$339K Buy
+1,959
New +$268K ﹤0.01% 908

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Commerce Bank's NVCR Position: Q2 2023 in Review

Commerce Bank sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 4,285 shares — an estimated $258K sold.

Commerce Bank first reported a position in NVCR in Q4 2020 and held it in 8 quarters. The position peaked at $519K in Q2 2021. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

  • Commerce Bank reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
  • Commerce Bank sold 4,285 NovoCure shares in Q2 2023, an estimated $258K.
  • Commerce Bank first reported a position in NovoCure in Q4 2020 and held it in 8 quarters.
  • Commerce Bank's NovoCure position peaked at $519K in Q2 2021.
  • 267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on Commerce Bank's 13F filing for Q2 2023, filed 8 Aug 2023.